All Videos

David Goldberg, MD, JD, shares some of the highlights that will be presented at this year's South Beach Symposium in Miami Beach, Florida.

Patricia Farris, MD, shares some of the highlights that will be presented at the 2023 South Beach Symposium in Miami Beach, Florida.

In this week’s Pointers with Dr Portela, the 208SkinDoc, reviews how some medications increase sun sensitivity.

Experts in dermatology discuss ruxolitinib, an exciting new therapy approved for repigmentation of the skin for patients with vitiligo.

Nada Elbuluk, MD, and David Rosmarin, MD, review treatments in vitiligo, including corticosteroids and phototherapy.

Aaron S. Farberg, MD, and Jeffrey Crowley, MD, discuss the importance of investigating the data on generalized pustular psoriasis, comorbidities of the disease, and commonly used treatments.

Experts in dermatology review data on various treatment interventions before, during, and after generalized pustular psoriasis flare episodes.

In this week’s Pointers with Dr Portela, the 208SkinDoc, asks consumers about the basics of skin health and skin care.

Nada Elbuluk, MD, and David Rosmarin, MD, discuss the role of the health care provider in helping patients understand their vitiligo and treatment options.

Experts in dermatology share their approaches to communicating with patients about their vitiligo, highlighting family history and genetic awareness.

Drs Mark G. Lebwohl and Alice B. Gottlieb discuss future expectations in the treatment of plaque psoriasis.

Aaron S. Farberg, MD, and Jeffrey Crowley, MD, examine the results of a study of generalized pustular psoriasis, discussing flares and common signs and symptoms.

Aaron S. Farberg, MD, and Jeffrey Crowley, MD, review the demographics of people with generalized pustular psoriasis including age, race, and comorbidities.

Following the 2022 Fall Clinical Dermatology meeting, Zoe Diana Draelos, MD; Mark G. Lebwohl, MD; Peter A. Lio, MD; and Elizabeth Swanson, MD, and engage in a rapid-fire question-and-answer sessions, hosted by Dermatology Times. Topics include most surprising new data, what needs follow-up, and the biggest winner out of the meeting.

Nada Elbuluk, MD, and David Rosmarin, MD, discuss screening patients with vitiligo for common comorbidities.

Nada Elbuluk, MD, and David Rosmarin, MD, provide an overview of vitiligo, its prevalence, and potential triggers.

Raj Chovatiya, MD, PhD, and Lisa Swanson, MD, FAAD, explore the impact of recent advances in atopic dermatitis treatment and look to future possibilities.

Raj Chovatiya, MD, PhD, and Lisa Swanson, MD, FAAD, review the challenges of identifying the right regimens for patients and the many factors that influence treatment selection.

Raj Chovatiya, MD, PhD, and Lisa Swanson, MD, FAAD, discuss how to talk about safety concerns with patients.

The author of a new study on JAK inhibitors discusses his surprising findings on the safety profiles of these new medications for dermatologic conditions.

Mark G. Lebwohl, MD, and Alice B. Gottlieb, MD, PhD, discuss gaps in care for the treatment of plaque psoriasis.

Expert dermatologists discuss the methods of a study of US health records of patients with generalized pustular psoriasis.

Aaron S. Farberg, MD, and Jeffrey Crowley, MD, provide an overview of generalized pustular psoriasis, identifying flares, the burden on patients, and available treatment options.

Robert Kirsner, MD, PhD, discusses how to heal difficult wounds at the 2022 SDPA Fall Conference.

At the 2022 SDPA Conference, Cynthia Trickett, PA-C, MPAS talks about her 2 sessions; psoriasis primer and kodachromes.

Renata Block, MMS, PA-C., explains the importance of The Society of Dermatology Physician Assistants (SDPA) 2022 Conference.

Shanna Miranti, MPAS, PA-C, shares highlights from her shared session at the 2022 SDPA Conference.

Shanna Miranti, MPAS, PA-C, shares highlights from her first session at the 2022 SDPA Conference in Miami, Florida.

In this week’s Pointers with Dr Portela, the 208SkinDoc reacts to questionable online beauty hacks.

Experts share clinical insights boxed warning for the JAK inhibitor drug class.